Related Experiment Video

Updated: May 12, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
04:40

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans

Published on: August 28, 2018

CT-based diagnosis of diffuse coronary artery disease on the basis of scaling power laws

Yunlong Huo1, Thomas Wischgoll, Jenny Susana Choy

  • 1Department of Biomedical Engineering, IUPUI, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, USA.

Radiology
|April 26, 2013
PubMed

Insights

Coronary computed tomography angiography can diagnose diffuse coronary artery disease (CAD) using a novel scaling analysis. This method quantitatively differentiates patients with metabolic syndrome from controls, aiding in diffuse CAD assessment.

Area of Science:

  • Cardiovascular Imaging
  • Biomedical Engineering
  • Radiology

Background:

  • Diffuse coronary artery disease (CAD) poses diagnostic challenges.
  • Coronary computed tomography (CT) angiography is a key imaging modality.
  • Quantitative analysis methods are needed for diffuse CAD assessment.

Purpose of the Study:

  • To establish a proof-of-concept for a diagnostic method for diffuse CAD.
  • To utilize coronary CT angiography data for this assessment.
  • To apply a scaling power law analysis to coronary artery morphology.

Main Methods:

  • Retrospective analysis of coronary CT angiography data from 120 subjects (89 with metabolic syndrome, 31 controls).
  • Morphometric analysis of the epicardial coronary artery tree using the scaling power law.
  • Statistical comparison of results between patients with metabolic syndrome and control subjects.

Main Results:

  • Patients with metabolic syndrome showed significantly smaller mean lumen cross-sectional area and intravascular volume compared to controls.
  • The length-volume power law revealed distinct coefficients between the groups.
  • Over 65% of patients with metabolic syndrome had a length-volume scaling coefficient ≥ 23, versus ~90% of controls with < 23.

Conclusions:

  • Retrospective scaling analysis offers a quantitative basis for diagnosing diffuse CAD.
  • Coronary CT angiography combined with scaling analysis can differentiate diffuse CAD.
  • This method provides a novel diagnostic approach for diffuse coronary artery disease.
Abstract

More Related Videos

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images06:57

Semi-Automatic Graphical Tool for Measuring Coronary Artery Spatially Weighted Calcium Score from Gated Cardiac Computed Tomography Images

Published on: September 22, 2023

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...